Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|March 24, 2022
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer CareBrandon S Sheffield, Andrea Beharry, Joanne Diep, et al.The American Journal of Surgical Pathology|September 29, 2023
Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1Mónica Fumero-Velázquez, Michael Hagstrom, Soneet Dhillon, et al.Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|February 11, 2015
Fatal congenital hypertrophic cardiomyopathy and a pancreatic nodule morphologically identical to focal lesion of congenital hyperinsulinism in an infant with costello syndrome: case report and review of the literatureBrandon S Sheffield, Stephen Yip, Eduardo D Ruchelli, et al.Current Oncology (Toronto, Ont.)|October 25, 2024
Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario PerspectiveDaniel Breadner, David M Hwang, Don Husereau, et al.Current Oncology (Toronto, Ont.)|March 26, 2025
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in CanadaBrandon S Sheffield, Shantanu Banerji, Allen Chankowsky, et al.Current Oncology (Toronto, Ont.)|November 26, 2024
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario ForumParneet K Cheema, Paul F Wheatley-Price, Matthew J Cecchini, et al.Plos One|April 27, 2018
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practiceLeah M Prentice, Ruth R Miller, Jeff Knaggs, et al.Current Oncology (Toronto, Ont.)|December 13, 2021
Canadian Consensus Recommendations on the Management of <i>MET</i>-Altered NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.Current Oncology (Toronto, Ont.)|December 27, 2024
Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction AdenocarcinomaChristine Brezden-Masley, Pierre O Fiset, Carol C Cheung, et al.Pageof 5